2. Marangella M. Use of citrate in patients with nephrolithiasis, G Ital Nefrol. 20171;34(4):51–60. PMID: 28762682;

3. Carvalho M., Erbano B.O., Kuwaki E.Y., Pontes H.P., Liu J., Boros L.H., Asinelli M.O., Baena C.P. Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Urolithiasis. 2016. Doi: 10.1007/s00240-016-0950-1.

4. Tracy C.R., Pearle M.S. Update on the medical management of stone disease. Curr Opin Urol. 2009;19(2):200–04.

5. Siener R. Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?Urolithiasis. 2016;44(1):51–56.

6. Byer K., Khan S.R. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol. 2005;173:640–646.

7. Kessler T., Jansen B., Hesse A. Effect of blackcurrant-, cranberry and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr. 2002;56:1020–1023.

8. Hönow R., Laube N., Schneider A., Kessler T., Hesse A. Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallisation. Br J Nutr. 2003;90:295–300.

9. Sulaiman S.K., Pietropaolo A., Aboumarzouk O., Somani Bh.K., Gamage K.N., Jamnadass E. The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades». Turk J Urol. 10.5152/tud.2020.20155

10. Pytel Yu.A., Zolotarev I.I. Urate nephrolithiasis. M., 1995. Russian (Пытель Ю.А., Золотарев И.И. Уратный нефролитиаз. М., 1995).

11. Rimer J.D., Sakhaee K., Maalouf N.M. Citrate therapy for calcium phosphate stones. Curr Opin Nephrol Hypertens. 2019;28(2):130–139.

12. Chutipongtanate S., Chaiyarit S., Thongboonkerd V. Citrate, not phosphate, can dissolve calcium oxalate monohydrate crystals and detach these crystals from renal tubular cell. Eur. J. Pharmacol. 2012;689:219–225.

13. Cho K.R., Salter E.A., De Yoreo J.J., Wierzbicki A., Elhadj S., Huang Y., Qiu S.R. Growth inhibition of calcium oxalate monohydrate crystal by linear aspartic acid enantiomers investigated by in situ atomic force microscopy. Cryst Eng Comm. 2013;15:54–64.

14. Qiu S.R., Wierzbicki A., Salter E.A., Zepeda S., Orme C.A., Hoyer J.R., Nancollas G.H., Cody A.M., De Yoreo J.J. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps. J. Am. Chem. Soc. 2005;127:9036–9044.

15. Farmanesh S., Ramamoorthy S., Chung J., Asplin J.R., Karande P., Rimer J.D. Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallizationJ. Am. Chem. Soc. 2014;136:367–376.

16. Wang L., Qiu S.R., Zachowicz W., Guan X., DeYoreo J.J., Nancollas G.H., Hoyer J.R. Langmuir. 2006;22:7279–7285.

17. Touhami M., Laroubi A., Elhabazi K., Loubna F., Zrara I., Eljahiri Y., Oussama A., Grases F.Х., Chait A. Lemon juice has protective activity in a rat urolithiasis model. BMC Urology. 2007:18 https://doi.org/10.1186/1471-2490-7-18

18. Aras B., Kalfazade N., Tugcu V., et al. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study. Urol Res. 2008;36:313–317.

19. Rahman F., Birowo P., Widyahening I.S., Rasyid N. Effect of citrus-based products on urine profile: A systematic review and meta-analysis. PMID: 28529700 PMCID: PMC5428529. doi: 10.12688/f1000research.10976.1.

20. Penniston K.L., Steele T.H., Nakada S.Y. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology. 2007;70:856–860.

21. Kang D.E., Sur R.L., Haleblian G.E., et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007;177:1358–1362.

22. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–838.

23. Curhan G.C., Willett W.C., Speizer F.E., et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497–504.

24. Barghouthy Y., Somani B.K. Role of citrus fruit juices in prevention of kidney stone disease (KSD): A narrative review. Nutrients 2021;13(11):4117.

25. Taylor E.N., Curhan G.C. Fructose consumption and the risk of kidney stones. Kidney Int 2008;73(2):207–212.

26. Ruggenenti P., Caruso M.R., Cortinovis M., et al. Fresh lemon juice supplementation for the prevention of recurrent stones in calcium oxalate nephrolithiasis: A pragmatic, prospective, randomised, open, blinded endpoint (PROBE) trial. E Clinical Medicine. 2021;43:101227.

27. Cirillo P., Gersch M.S., Mu W., Scherer P.M., Kim K.M., Gesualdo L., et al. Ketohexokinasedependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol. 2009;20(3):545–553.

28. Shoham D.A., Durazo-Arvizu R., Kramer H., Luke A., Vupputuri S., Kshirsagar A., et al. Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One. 2008; 3(10):e3431.

29. Nguyen N.U., Dumoulin G., Henriet M.T., Regnard J. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res. 1995;27:155–158.

30. Fox I.H., Kelley W.N. Studies on the mechanism of fructoseinduced hyperuricemia in man. Metabolism. 1972;21:713–721.

31. Odvina V. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Randomized controlled trial. Clin J Am Soc Nephrol. 2006;1(6):1269–74. Doi: 10.2215/cjn.00800306.

32. Gopala S.K., Joe J., Chandran J. Effects of lemon–tomato juice consumption on crystal formation in the urine of patients with calcium oxalate stones: A randomized crossover clinical trial. Current Urology. 2023;17(1):25–29. doi: 10.1097/CU9.0000000000000178.

33. Kang D.E., Sur R.L., Haleblian G.E., Fitzsimons N.J., Borawski K.M., Preminger G.M. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J. Urol. 2007;177:1358–1362.

34. Koff S.G., Paquette E.L., Cullen J., Gancarczyk K.K., Tucciarone P.R., Schenkman N.S. Comparison between lemonade and potassium citrate and impact on urine pH and 24-h urine parameters in patients with kidney stone formation. Urology. 2007;69:1013–1016.

35. Cheng J.W., Wagner H., Asplin J.R., Hodgkin G., Schlaifer A., Fargusson M., Fargusson J., Baldwin D.D. The Effect of Lemonade and Diet Lemonade Upon Urinary Parameters Affecting Calcium Urinary Stone Formation. J Endourol. 2019;33(2):160–166. doi: 10.1089/end.2018.0623

36. Zuckerman J.M., Assimos D.G. Hypocitraturia: Pathophysiology and medical management. Rev Urol. 2009;11:134–144.

37. Sakhaee K., Alpern R., Poindexter J., Pak C.Y. Citraturic response to oral citric acid load. J Urol. 1992;147:975–976.

38. Weiner I.D., Wingo C.S. Hypokalemia–consequences, causes and correction. J Am Soc Nephrol. 1997;8:1179–1188.

39. da Cunha Baia L., Baxmann A.C., Moreira S.R., Holmes R.P., Heilberg I.Pf. Noncitrus Alkaline Fruit: A Dietary Alternative for the Treatment of Hypocitraturic Stone Formers. J Endourol. 2012;26(9):1221–1226. doi: 10.1089/end.2012.0092

40. Siddiquia W.A., Shahzada M., Shabbirb A., Ahmadc A. Evaluation of anti-urolithiatic and diuretic activities of watermelon (Citrullus lanatus) using in vivo and in vitro experiments. Biomedicine & Pharmacotherapy. 2018;97:1212–1221.

41. Barghouthy Y., Somani B.K. Role of citrus fruit juices in prevention of kidney stone disease (KSD): A narrative review. Nutrients. 2021;13(11):4117.

42. McHarg T., Rodgers A., Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int. 2003;92(7):765–768. doi: 10.1046/j.1464-410x.2003.04472.x.

43. Bodel P.T., Cortran R., Kass E.H. Cranberry juice and the antibacterial action of hippuric acid. J. Lab. Clin. Med. 1959;54:881–888.

44. Raz R., Chazan B., Dan M. Cranberry Juice and Urinary Tract Infection. Clinical Infectious Diseases. 2004;38(10):1413–1419.

45. Avron J., Monane M., Gurwitz J.H., Glynn J., Choodnovsky I., Lipsitz L.A. Reduction of bacteruria and pyuria after ingestion of cranberry juice. JAMA. 1994;271:751–754.

46. Howell A.B., Vorsa N., Marderosian A.D., Foo L.Y. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. New Engl. J. Med. 1998;339:1085–1086.

47. Frassetto L., Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011;84(11):1234–42.

48. Keßler T., Jansen B., Hesse A. Effect of blackcurrant-, cranberry- and plum juice consumption on risk factors associated with kidney stone formation. European Journal of Clinical Nutrition. 2002;56:1020–1023. doi: 10.1038/sj.ejcn.1601442

49. Kelly E., Vyas P., Weber J.T. Biochemical Properties and Neuroprotective Effects of Compounds in Various Species of Berries. Molecules. 2017;23(1):E26. doi: 10.3390/molecules23010026.

50. Szakiel A., Mroczek A. Distribution of triterpene acids and their derivatives in organs of cowberry (Vaccinium vitis-idaea L.) plant. Acta Biochim Pol. 2007;54(4):733–40.

51. Ghalayini I.F., Al-Ghazo M.A., Harfeil M.N. Prophylaxis and therapeutic effects of raspberry (Rubus idaeus) on renal stone formation in Balb/c mice. Int. Braz. J. Urol. 2011;37:259–267.

52. Zhang Y., Zhang Z., Yang Y., Zu X., Guan D., Guan, Y. Diuretic activity of Rubus idaeus L (Rosaceae) in rats. Trop. J. Pharm. Res. 2011;10.

53. Bhandari P.R. Pomegranate (Punica granatum L). Ancient seeds for modern cure? Review of potential therapeutic applications. Int. J. Nutr. Pharmacol. Neurol. Dis. 2012;2:171–184.

54. Tugcu V., et al. Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J. Endourol. 2008;22:2723–2732.

55. Bagri P., Ali M., Aeri V., Bhowmik M., Sultana S. Antidiabetic effect of Punica granatum flowers: Effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem. Toxicol. 2009;47:50–54.

56. Ilbey Y.O., Ozbek E., Simsek A., Cekmen M., Somay A., Tasci A.I. Effects of pomegranate juice on hyperoxaluria-induced oxidative stress in the rat kidneys. Ren. Fail. 2009;31:522–531.

57. Tracy C.R., Henning J.R., Newton M.R., Aviram M., Zimmerman M.B. Oxidative stress and nephrolithiasis: A comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls. Urolithiasis. 2014;42:401–408.

58. Zhang Y., Coca A., Casa D.J., Antonio J., Green J.M., Bishop P.A. Caffeine and diuresis during rest and exercise: a metaanalysis. J Sci Med Sport. 2015;18:569–574.

59. Massey L.K., Sutton R.A. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol. 2004;172:555–558.

60. Robertson G.L. Regulation of vasopressin secretion. In: Seldin DW, Giebisch G, eds. The kidney: physiology and pathophysiology, 2nd ed. New York: Raven Press, 1992.

61. Bigotte V.M., Magrico R., Viegas Dias C., Leitao L., Neves J.S. Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis. Nephrol Dial Transpl. 2019;34:974–980.

62. Neves J.S., Leitao L., Magrico R. Caffeine consumption and mortality in diabetes: an analysis of NHANES 1999–2010. Front Endocrinol. 2018;9:547.

63. Wu Z.B., Jiang T., Lin G.B. et al. Tea consumption is associated with increased risk of kidney stones in Northern Chinese: a cross-sectional Study. Biomed Environ Sci. 2017;30:922–926.

64. Sun Y., Wang D., Zhou Q. Caffeine intake and the risk of recurrent kidney stones in adults, an analysis of 2007–2014 National Health and Nutrition Examination Surveys. European Journal of Nutrition https://doi.org/10.1007/s00394-019-02115-0

65. Xiang Shu, Hui Cai, Yong-Bing Xiang, Honglan Li, Loren Lipworth, Nicole L Miller, Wei Zheng, Xiao-Ou Shu, Ryan S Hsi. Green tea intake and risk of incident kidney stones: Prospective cohort studies in middle-aged and elderly Chinese individuals. Int J Urol. 2019;26(2):241–246. doi: 10.1111/iju.13849.

66. Zeng G., Mai Z., Xia S. et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017; 120: 109–16.4, Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clin. J. Am. Soc. Nephrol. 2013; 8: 1389–1395.

67. Itoh Y., Yasui T., Okada A., Tozawa K., Hayashi Y., Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J. Urol. 2005;173:271–275.

68. Jeong B.C., Kim B.S., Kim J.I., Kim H.H. Effects of green tea on urinary stone formationn in vivo and in vitro study. J. Endourol. 2006;20:356–361.

69. Massey L.K., Wise K.J. Impact of gender and age on urinary water and mineral excretion responses to acute caffeine doses. Nutr. Res. 1992;12:605–612.

70. Jeong B.C., Kim B.S., Kim J.I., Kim H.H. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J. Endourol. 2006;20:356–61.

71. Kanlaya R., Singhto N., Thongboonkerd V. EGCG decreases binding of calcium oxalate monohydrate crystals onto renal tubular cells via decreased surface expression of alpha-enolase. J. Biol. Inorg. Chem. 2016;21:339–346.

72. Rodgers A., Mokoena M., Durbach I., et al. Do teas rich in antioxidants reduce the physicochemical and peroxidative risk factors for calcium oxalate nephrolithiasis in humans? Pilot studies with Rooibos herbal tea and Japanese green tea. Urolithiasis. 2016;44:299–310.

73. Garrel D.R., Verdy M., PetitClerc C. et al. Milk – and soy-protein ingestion: acute effect on serum uric acid concentration

74. Ghadirian P., Shatenstein B., Verdy M. et al. The influence of dairy products on plasma uric acid in women

75. Simmonds H.A., Webster D.R., Becroft D.M. et al. Purine and pyrimidine metabolism in hereditary orotic aciduria: some unexpected effects of allopurinol

76. Non-Dairy Milk Market- Global Outlook and Forecast 2019-2024. https://www.reportbuyer.com/product/5758037/non-dairy-milk-market-global-outlook-and-forecast-2019-2024.html?utm_source=PRN. Accessed July 18, 2020.

77. Storhaug C.L., Fosse S.K., Fadnes L.T. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:738.

78. Borin J.F., Knight J., Holmes R.P., Joshi Sh., Goldfarb D.S., Loeb S. Plant-Based Milk Alternatives and Risk Factors for Kidney Stones and Chronic Kidney Disease. J Ren Nutr. 2022;32(3):363–365. doi: 10.1053/j.jrn.2021.03.011.

79. Dmitriev V.N. Grape treatment in Yalta on the southern coast of Crimea. M., 1878. Russian (Дмитріевъ В.Н. Лечение виноградом в Ялте на южном берегу Крыма. M., 1878).

80. de Lorimier A.A. Alcohol, wine, and health. Review Am J Surg. 2000;180(5):357–61. doi: 10.1016/s0002-9610(00)00486-4

81. Zecher M., Guichard Cr., Velásquez M.J., Figueroa G., Rodrigo R. Implications of oxidative stress in the pathophysiology of obstructive uropathy. Urol Res. 2009;37(1):19–26. doi: 10.1007/s00240-008-0163-3.

82. Truelsen T., Gronbaek M., Schnohr P., Boysen G. Intake of beer, wine, and spirits and risk of stroke: the copenhagen city heart study. Stroke. 1998;29(12):2467–2472. doi: 10.1161/01.str.29.12.2467.

83. Ferraro P.M., Taylor E.N., Gambaro G., Curhan G.C. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8(8):1389–1395. doi: 10.2215/CJN.11661112

84. Eisenhofer G., Johnson R.H. Effect of ethanol ingestion on plasma vasopressin and water balance in humans. Am J Physiol. 1982;242:R522–R527.

85. Goldsmith S.R., Dodge D. Response of plasma vasopressin to ethanol in congestive heart failure. Am J Cardiol. 1985;55:1354–1357.

86. Havlová P., Šusta J. Stanovení kyseliny šťavelové ve sladu a pivu. Kvas. Prům. 1997;43(2):37–38.

87. Sperkowska B., Bazylak G. Analiza zawartości szcza-wianów w naparach czarnych herbat i kaw dostępnych na polskim rynku. Nauka Przyr. Technol. 2010;4(3):1–13.

88. Sperkowska B., Bazylak G. Ocena zawartości rozpusz-czalnych szczawianów w herbatach zielonych i popu-larnych naparach ziołowych. Bromat. Chem. Toksykol. 2010;43(2):130–137.

89. Salamon Ag., Baca E., Baranowski Kr., Michałowska D. The evaluation of anti-nutritive components in beer on the example of oxalic acid. Rocz Panstw Zakl Hig. 2012;63(1):37–42.

90. Beer in Health and Disease Prevention / Edited by Victor R. Preedy. – Amsterdam; Boston: Elsevier / Academic Press, 2009. 1248 p.

91. Chang Xu, Chao Zhang, Xiao-Long Wang, Tong-Zu Liu, Xian-Tao Zeng, Shen Li, Xiao-Wen Duan. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose–Response Meta-Analysis of Observational Studies. Logo of medicine. Medicine (Baltimore). 2015l;94(27):e1042. doi: 10.1097/MD.0000000000001042

92. Curhan G.C., Willett W.C., Rimm E.B., Spiegelman D., Stampfer M.J. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143(3):240–247. doi: 10.1093/oxfordjournals.aje.a008734